541 related articles for article (PubMed ID: 32142359)
21. Diabetic cardiomyopathy: mechanisms and new treatment strategies targeting antioxidant signaling pathways.
Huynh K; Bernardo BC; McMullen JR; Ritchie RH
Pharmacol Ther; 2014 Jun; 142(3):375-415. PubMed ID: 24462787
[TBL] [Abstract][Full Text] [Related]
22. FT011, a new anti-fibrotic drug, attenuates fibrosis and chronic heart failure in experimental diabetic cardiomyopathy.
Zhang Y; Edgley AJ; Cox AJ; Powell AK; Wang B; Kompa AR; Stapleton DI; Zammit SC; Williams SJ; Krum H; Gilbert RE; Kelly DJ
Eur J Heart Fail; 2012 May; 14(5):549-62. PubMed ID: 22417655
[TBL] [Abstract][Full Text] [Related]
23. Antifibrotic cardioprotection of berberine via downregulating myocardial IGF-1 receptor-regulated MMP-2/MMP-9 expression in diabetic rats.
Li G; Xing W; Zhang M; Geng F; Yang H; Zhang H; Zhang X; Li J; Dong L; Gao F
Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H802-H813. PubMed ID: 29957017
[TBL] [Abstract][Full Text] [Related]
24. Angiotensin-(1-7) treatment mitigates right ventricular fibrosis as a distinctive feature of diabetic cardiomyopathy.
Hao PP; Yang JM; Zhang MX; Zhang K; Chen YG; Zhang C; Zhang Y
Am J Physiol Heart Circ Physiol; 2015 May; 308(9):H1007-19. PubMed ID: 25724492
[TBL] [Abstract][Full Text] [Related]
25. Type 1 diabetic cardiomyopathy in the Akita (Ins2WT/C96Y) mouse model is characterized by lipotoxicity and diastolic dysfunction with preserved systolic function.
Basu R; Oudit GY; Wang X; Zhang L; Ussher JR; Lopaschuk GD; Kassiri Z
Am J Physiol Heart Circ Physiol; 2009 Dec; 297(6):H2096-108. PubMed ID: 19801494
[TBL] [Abstract][Full Text] [Related]
26. Sulforaphane prevents the development of cardiomyopathy in type 2 diabetic mice probably by reversing oxidative stress-induced inhibition of LKB1/AMPK pathway.
Zhang Z; Wang S; Zhou S; Yan X; Wang Y; Chen J; Mellen N; Kong M; Gu J; Tan Y; Zheng Y; Cai L
J Mol Cell Cardiol; 2014 Dec; 77():42-52. PubMed ID: 25268649
[TBL] [Abstract][Full Text] [Related]
27. Functional resilience of C57BL/6J mouse heart to dietary fat overload.
Tadinada SM; Weatherford ET; Collins GV; Bhardwaj G; Cochran J; Kutschke W; Zimmerman K; Bosko A; O'Neill BT; Weiss RM; Abel ED
Am J Physiol Heart Circ Physiol; 2021 Nov; 321(5):H850-H864. PubMed ID: 34477461
[TBL] [Abstract][Full Text] [Related]
28. Glucagon-like peptide-1 receptor activation reverses cardiac remodeling via normalizing cardiac steatosis and oxidative stress in type 2 diabetes.
Monji A; Mitsui T; Bando YK; Aoyama M; Shigeta T; Murohara T
Am J Physiol Heart Circ Physiol; 2013 Aug; 305(3):H295-304. PubMed ID: 23709595
[TBL] [Abstract][Full Text] [Related]
29. Allopurinol attenuates left ventricular dysfunction in rats with early stages of streptozotocin-induced diabetes.
Gao X; Xu Y; Xu B; Liu Y; Cai J; Liu HM; Lei S; Zhong YQ; Irwin MG; Xia Z
Diabetes Metab Res Rev; 2012 Jul; 28(5):409-17. PubMed ID: 22389139
[TBL] [Abstract][Full Text] [Related]
30. Chronic administration of the nitroxyl donor 1-nitrosocyclo hexyl acetate limits left ventricular diastolic dysfunction in a mouse model of diabetes mellitus in vivo.
Cao N; Wong YG; Rosli S; Kiriazis H; Huynh K; Qin C; Du XJ; Kemp-Harper BK; Ritchie RH
Circ Heart Fail; 2015 May; 8(3):572-81. PubMed ID: 25737497
[TBL] [Abstract][Full Text] [Related]
31. EGFR inhibition protects cardiac damage and remodeling through attenuating oxidative stress in STZ-induced diabetic mouse model.
Liang D; Zhong P; Hu J; Lin F; Qian Y; Xu Z; Wang J; Zeng C; Li X; Liang G
J Mol Cell Cardiol; 2015 May; 82():63-74. PubMed ID: 25758431
[TBL] [Abstract][Full Text] [Related]
32. Intravenous gene therapy with PIM-1 via a cardiotropic viral vector halts the progression of diabetic cardiomyopathy through promotion of prosurvival signaling.
Katare R; Caporali A; Zentilin L; Avolio E; Sala-Newby G; Oikawa A; Cesselli D; Beltrami AP; Giacca M; Emanueli C; Madeddu P
Circ Res; 2011 May; 108(10):1238-51. PubMed ID: 21474815
[TBL] [Abstract][Full Text] [Related]
33. Cardioprotective effects of polydatin against myocardial injury in diabetic rats via inhibition of NADPH oxidase and NF-κB activities.
Tan YY; Chen LX; Fang L; Zhang Q
BMC Complement Med Ther; 2020 Dec; 20(1):378. PubMed ID: 33308195
[TBL] [Abstract][Full Text] [Related]
34. GCN2 deficiency ameliorates cardiac dysfunction in diabetic mice by reducing lipotoxicity and oxidative stress.
Feng W; Lei T; Wang Y; Feng R; Yuan J; Shen X; Wu Y; Gao J; Ding W; Lu Z
Free Radic Biol Med; 2019 Jan; 130():128-139. PubMed ID: 30389499
[TBL] [Abstract][Full Text] [Related]
35. Worse cardiac remodeling in response to pressure overload in type 2 diabetes mellitus.
Gonçalves N; Gomes-Ferreira C; Moura C; Roncon-Albuquerque R; Leite-Moreira AF; Falcão-Pires I
Int J Cardiol; 2016 Aug; 217():195-204. PubMed ID: 27195451
[TBL] [Abstract][Full Text] [Related]
36. Dominant-negative p38alpha mitogen-activated protein kinase prevents cardiac apoptosis and remodeling after streptozotocin-induced diabetes mellitus.
Thandavarayan RA; Watanabe K; Ma M; Gurusamy N; Veeraveedu PT; Konishi T; Zhang S; Muslin AJ; Kodama M; Aizawa Y
Am J Physiol Heart Circ Physiol; 2009 Sep; 297(3):H911-9. PubMed ID: 19617408
[TBL] [Abstract][Full Text] [Related]
37. Activation of myocardial phosphoinositide-3-kinase p110α ameliorates cardiac dysfunction and improves survival in polymicrobial sepsis.
Li C; Hua F; Ha T; Singh K; Lu C; Kalbfleisch J; Breuel KF; Ford T; Kao RL; Gao M; Ozment TR; Williams DL
PLoS One; 2012; 7(9):e44712. PubMed ID: 23028587
[TBL] [Abstract][Full Text] [Related]
38. Assessment of cardiac inflammation and remodeling during the development of streptozotocin-induced diabetic cardiomyopathy in vivo: a time course analysis.
Becher PM; Lindner D; Fröhlich M; Savvatis K; Westermann D; Tschöpe C
Int J Mol Med; 2013 Jul; 32(1):158-64. PubMed ID: 23652584
[TBL] [Abstract][Full Text] [Related]
39. Coenzyme Q10 attenuates diastolic dysfunction, cardiomyocyte hypertrophy and cardiac fibrosis in the db/db mouse model of type 2 diabetes.
Huynh K; Kiriazis H; Du XJ; Love JE; Jandeleit-Dahm KA; Forbes JM; McMullen JR; Ritchie RH
Diabetologia; 2012 May; 55(5):1544-53. PubMed ID: 22374176
[TBL] [Abstract][Full Text] [Related]
40. Cardiac proteasome functional insufficiency plays a pathogenic role in diabetic cardiomyopathy.
Li J; Ma W; Yue G; Tang Y; Kim IM; Weintraub NL; Wang X; Su H
J Mol Cell Cardiol; 2017 Jan; 102():53-60. PubMed ID: 27913284
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
